-
1تقرير
المؤلفون: Meredith, Luke, Chao, Timothy, Nevler, Avinoam, Mallick, Atrayee Basu, Singla, Rajan, McCue, Peter, Bowne, Wilbur, Jiang, MD, PhD, Wei
المصدر: Kimmel Cancer Center Faculty Papers
مصطلحات موضوعية: humans, male, MTOR inhibitors, mutation, perivascular epithelioid cell neoplasms, sarcoma, sirolimus, TOR serine-threonine kinases, Genomics, Medical Pathology, Oncology, Surgery
وصف الملف: application/pdf
العلاقة: https://jdc.jefferson.edu/kimmelccfp/99Test; https://jdc.jefferson.edu/context/kimmelccfp/article/1099/viewcontent/Rare_Metastatic_Mesenteric_Malignant_PEComa.pdfTest; https://jdc.jefferson.edu/context/kimmelccfp/article/1099/filename/0/type/additional/viewcontent/Supplemental_Figure.docxTest
-
2تقرير
مصطلحات موضوعية: Thymus, Lymphocytes, Immunosuppressants, Cellular respiration, mTOR inhibitors, Sirolimus, Everolimus, PI3K inhibitors, Calcineurin inhibitors, Sorafenib, Idelalisib
-
3رسالة جامعية
المؤلفون: Koenig, Alice
مرشدي الرسالة: Lyon, Thaunat, Olivier
مصطلحات موضوعية: Cellule Natural Killer, Rejet chronique, Missing-self, Transplantation, Inhibiteurs de mTOR, NK cell, Chronic rejection, MTOR inhibitors, 570
-
4تقرير
-
5تقرير
المؤلفون: Kirby, Sean, Satoskar, Anjali, Brodsky, Sergey, Pope-Harman, Amy, Nunley, David, Hitchcock, Charles, Pelletier, Ronald, Ross, Patrick, Nadasdy, Tibor, Shilo, Konstantin
-
6تقرير
المصدر: Efficacy of OSFIT Drug-Eluting Stent in Coronary Ostial Artery Stenosis: Multi-center, Prospective, Observational Study (OSFIT Registry)
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06066450Test
-
7تقرير
المصدر: Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy. A 2x2 Factorial, All-comer, Multicenter, Randomized Controlled Trial: ANGIODAPT
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05952206Test
-
8تقرير
المساهمون: Frances Valdes-Albini, Assistant Professor of Clinical Medicine
المصدر: Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer: A Phase 2 Randomized, Open-Label Study
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05826964Test
-
9تقرير
المساهمون: Nader Sanai, Director of the Ivy Brain Tumor Center
المصدر: A Phase 0, Single-center, Open-label, Dose-escalating Trial Using Super-selective Intra-arterial Infusion of a Single Dose of Temsirolimus for the Treatment of Recurrent High-grade Glioma
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05773326Test
Other URLs: http://ivybraintumorcenter.orgTest
-
10تقرير
المصدر: A Phase 1, Open-label, Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05661461Test